Amplify Weight Loss Drug & Treatment ETF (THNR)

THNR Holdings Information

THNR is an equity ETF with a total of 24 individual holdings. The top holdings are Eli Lilly and Company stock at 13.25%, Novo Nordisk at 12.64%, Chugai Pharmaceutical at 6.59%, Amgen at 6.51%, and Regeneron Pharmaceuticals at 6.27%.

• Total Holdings: 24
• Top 10 Percentage: 70.22%
• Asset Class: Equity
• ETF Category: Health
• Assets: 2.70M
• PE Ratio: 19.24

Top 25 Holdings

As of Oct 9, 2025

Filter results

No.	Symbol	Name	% Weight	Shares
1	LLY	Eli Lilly and Company	13.25%	418
2	NVO	Novo Nordisk A/S	12.64%	5,815
3	TYO: 4519	Chugai Pharmaceutical Co., Ltd.	6.59%	3,700
4	AMGN	Amgen Inc.	6.51%	595
5	REGN	Regeneron Pharmaceuticals, Inc.	6.27%	297
6	HIMS	Hims & Hers Health, Inc.	5.27%	2,440
7	SWX: ROG	Roche Holding AG	5.07%	375
8	ABBV	AbbVie Inc.	4.91%	574
9	AZN	AstraZeneca PLC	4.90%	1,556
10	MRK	Merck & Co., Inc.	4.81%	1,483
11	HKG: 1801	Innovent Biologics, Inc.	4.76%	10,500
12	PFE	Pfizer Inc.	4.75%	5,080
13	TYO: 4507	Shionogi & Co., Ltd.	4.31%	7,000
14	HKG: 1093	CSPC Pharmaceutical Group Limited	4.30%	96,000
15	CPH: ZEAL	Zealand Pharma A/S	3.20%	1,103
16	SRRK	Scholar Rock Holding Corporation	1.95%	1,286
17	HKG: 1276	Jiangsu Hengrui Medicine Co., Ltd.	1.84%	4,400
18	MTSR	Metsera, Inc.	1.57%	808
19	HKG: 3933	The United Laboratories International Holdings Limited	1.21%	18,000
20	KRX: 128940	Hanmi Pharm. Co., Ltd.	1.03%	110
21	AGPXX	Short-Term Investment Trust - Invesco Government & Agency Portfolio	0.57%	15,383
22	n/a	DEPOSITS WITH BROKER FOR SHORT POSITIONS	0.29%	86,317,523
23	n/a	HONG KONG DOLLAR	0.00%	3
24	n/a	US DOLLARS	-0.00%	25